EMEIS has issued a statement regarding transactions on its own shares for the period from October 20 to October 22, 2025, according to a company press release.
EMEIS announced the results of its share buyback program for the period from October 20 to October 22, 2025. During this period, a total of 26,433 shares were repurchased at an average weighted price of 14.6999 euros per share, according to the company's press release. The transactions were recorded under the ISIN code FR001400NLM4.
Company Profile and Operations
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
EMEIS, employing approximately 83,500 health and support professionals, operates in about twenty countries. The company operates in various sectors, including psychiatric clinics, medical and rehabilitation care, nursing homes, home care services, and serviced residences. EMEIS annually welcomes around 280,000 residents and patients.
Corporate Mission and Ownership
Since June 2025, EMEIS has adopted the status of a mission-driven company, incorporating commitments such as the inclusion of vulnerable people, the attractiveness of care professions, and ecological innovation. The company is 50.3% owned by institutional partners such as Caisse des Dépôts and CNP Assurances, and is listed on Euronext Paris. It is part of the SBF 120, CAC Mid 60, and CAC All-Tradable indices.
SectorSanté · Etablissements de santé / EHPAD›Etablissements de santé
Context
Period
Period: 9M 2025
Guidance from the release
Croissance organique soutenue (+6,4% à fin septembre 2025, +7,0% au T3), amélioration notable des taux d'occupation, objectifs de cessions dépassés (2,1 Md€) et confirmation des perspectives 2025 et de la trajectoire 2024-2028.
Risks mentioned
Risques et incertitudes liés aux conditions de marché futures pouvant affecter les résultats prévisionnels
Risque de non-réalisation ou de délai des cessions actuellement sécurisées ou en négociation
Impact transitoire des ouvertures récentes sur les taux d'occupation dans certaines zones
Opportunities identified
Croissance démographique des plus de 75 ans (+30% d'ici 10 ans) créant une demande structurelle accrue
Déficit structurel d'offre (déficit attendu de lits sur principaux marchés) offrant une forte visibilité commerciale
Possibilités de capture d'effets prix favorables et d'amélioration de marges opérationnelles
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
